AU4802699A - Pharmaceutical composition having improved taste - Google Patents

Pharmaceutical composition having improved taste Download PDF

Info

Publication number
AU4802699A
AU4802699A AU48026/99A AU4802699A AU4802699A AU 4802699 A AU4802699 A AU 4802699A AU 48026/99 A AU48026/99 A AU 48026/99A AU 4802699 A AU4802699 A AU 4802699A AU 4802699 A AU4802699 A AU 4802699A
Authority
AU
Australia
Prior art keywords
drug
pharmaceutical composition
gelling agent
composition according
containing substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48026/99A
Other languages
English (en)
Inventor
Hirofumi Doi
Masaaki Odomi
Yoshinao Onishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU4802699A publication Critical patent/AU4802699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU48026/99A 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste Abandoned AU4802699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31
JP10/217517 1998-07-31
PCT/JP1999/004046 WO2000006122A1 (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Publications (1)

Publication Number Publication Date
AU4802699A true AU4802699A (en) 2000-02-21

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48026/99A Abandoned AU4802699A (en) 1998-07-31 1999-07-26 Pharmaceutical composition having improved taste

Country Status (10)

Country Link
EP (1) EP1100466A1 (zh)
KR (1) KR20010072151A (zh)
CN (1) CN1161106C (zh)
AR (1) AR019485A1 (zh)
AU (1) AU4802699A (zh)
BR (1) BR9912533A (zh)
CA (1) CA2338996A1 (zh)
HK (1) HK1040191A1 (zh)
ID (1) ID28910A (zh)
WO (1) WO2000006122A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440412A1 (en) 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
US6767557B2 (en) 2001-03-05 2004-07-27 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
US20070053981A1 (en) * 2003-07-11 2007-03-08 Eva Blychert Solid composition comprising a proton pump inhibitor
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
WO2005120458A1 (ja) 2004-06-07 2005-12-22 Kureha Corporation 乾燥形態経口摂取用組成物及び用時調製形ゲル状経口摂取用組成物
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
WO2011149814A2 (en) * 2010-05-24 2011-12-01 Amerilab Technologies, Inc. Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
JP5976657B2 (ja) * 2011-09-30 2016-08-24 持田製薬株式会社 易服用性固形製剤
WO2018155435A1 (ja) * 2017-02-21 2018-08-30 Ｅａファーマ株式会社 顆粒製剤
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
JP3470198B2 (ja) * 1995-05-02 2003-11-25 大正製薬株式会社 経口投与用組成物
EA000467B1 (ru) * 1995-07-21 1999-08-26 Дайити Фармасьютикал Ко., Лтд. Гранулированный препарат и способ его получения
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives

Also Published As

Publication number Publication date
ID28910A (id) 2001-07-12
BR9912533A (pt) 2002-02-13
EP1100466A1 (en) 2001-05-23
HK1040191A1 (zh) 2002-05-31
CN1161106C (zh) 2004-08-11
KR20010072151A (ko) 2001-07-31
CA2338996A1 (en) 2000-02-10
CN1316899A (zh) 2001-10-10
AR019485A1 (es) 2002-02-20
WO2000006122A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
JPH10502390A (ja) 医薬品用の徐放性マトリックス
JP2000509399A (ja) 味隠蔽された懸濁液
IL147212A (en) Process to create coated kernels with camouflaged flavor
KR20000069899A (ko) 속방성 및 미각 차폐성 약제학적 용량 형태
JP2000103730A (ja) 服用感が改善された医薬組成物
AU2005261958A1 (en) Granules for controlled release of Tamsulosin
JP2000191519A (ja) 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
AU4802699A (en) Pharmaceutical composition having improved taste
JP5046463B2 (ja) 徐放性医薬組成物
JPH0819003B2 (ja) 有核顆粒およびその製造法
CA3025721C (en) Pharmaceutical compositions comprising safinamide
JP3833314B2 (ja) 発泡性組成物およびその製造方法
CN101754754B (zh) 含有包覆的含药物的颗粒的可分散药片及其制备方法
JP4705747B2 (ja) 薬剤組成物
EP3735238A1 (en) A stable oral pharmaceutical composition of ferric citrate
AU732210B2 (en) Colonic delivery of weak acid drugs
EP1600157A1 (en) Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same
KR101680925B1 (ko) 불쾌미 마스킹 입자 및 이것을 함유하는 경구제제
JP3466921B2 (ja) 味マスキング医薬製剤
US20040253309A1 (en) Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
KR20030076634A (ko) 의약 조성물
MXPA01001153A (en) Pharmaceutical composition having improved taste
EP3558261B1 (en) Pharmaceutical compositions comprising safinamide
CN111432806A (zh) 包含沙芬酰胺的药物组合物
EA046049B1 (ru) Фармацевтическая композиция, включающая сафинамид

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted